Fang, X., Monk, J. M., Mih, N., Du, B., Sastry, A. V., Kavvas, E., . . . Palsson, B. O. (2018). Escherichia coli B2 strains prevalent in inflammatory bowel disease patients have distinct metabolic capabilities that enable colonization of intestinal mucosa. BMC Syst Biol.
Citação norma ChicagoFang, Xin, Jonathan M. Monk, Nathan Mih, Bin Du, Anand V. Sastry, Erol Kavvas, Yara Seif, Larry Smarr, and Bernhard O. Palsson. "Escherichia Coli B2 Strains Prevalent in Inflammatory Bowel Disease Patients Have Distinct Metabolic Capabilities That Enable Colonization of Intestinal Mucosa." BMC Syst Biol 2018.
MLA citiranjeFang, Xin, et al. "Escherichia Coli B2 Strains Prevalent in Inflammatory Bowel Disease Patients Have Distinct Metabolic Capabilities That Enable Colonization of Intestinal Mucosa." BMC Syst Biol 2018.